The "Evaluation Index System for Calcium Channel Blocker Drugs in Medical Institutions" follows the principles of openness, transparency and fairness, takes relevant guidelines as the theoretical basis, combines the characteristics of clinical medication, and widely adopts the opinions and evaluation standards of drug use, monitoring and management personnel in medical institutions. It is highly scientific, specific and timely, and can be used as a reference for medical institutions at all levels. It is conducive to promoting the selection of drug catalogs for medical and health institutions and the connection between the drug catalogs of superior and lower-level medical and health institutions, improving the level of pharmaceutical services and rational drug use of calcium channel blocker drugs, controlling unreasonable drug expenses, and improving the efficiency of health resource allocation. It has a relatively great application value.
T/HENANPA 011-2023 history
2023T/HENANPA 011-2023 Evaluation index system for calcium channel blocker drugs in medical institutions